Nuzenio

Sarepta Therapeutics

Sarepta Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Sarepta Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocusGuruFocus · Sat, 08 Aug 2026 19:32:01 GMTSarepta Shares Rise As Company Begins Enrollment In Gene Therapy Safety Enhancement Study - StocktwitsStocktwits · Sat, 08 Aug 2026 11:59:18 GMTSarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer - simplywall.stsimplywall.st · Sat, 08 Aug 2026 10:47:29 GMTSarepta Stock Dips After Hours: DMD Drug Blow And CEO Exit Eclipse Q4 Revenue Beat - StocktwitsStocktwits · Fri, 07 Aug 2026 17:26:02 GMTState Street (NYSE: STT) discloses 8.4% Sarepta Therapeutics ownership via Schedule 13G - Stock TitanStock Titan · Fri, 07 Aug 2026 14:55:22 GMTSarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy - StocktwitsStocktwits · Fri, 07 Aug 2026 12:06:44 GMTSAREPTA THERAPEUTICS, INC. : OPPENHEIMER CUTS TARGET PRICE TO $35 FROM $37 - BitgetBitget · Fri, 07 Aug 2026 02:54:52 GMTSarepta Therapeutics (SRPT) Stock Rally Hinges On Profit Progress And Revenue Drop - simplywall.stsimplywall.st · Fri, 07 Aug 2026 00:04:01 GMT

Timeline

Sat, 08 Aug 2026 19:32:01 GMTSarepta Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Sat, 08 Aug 2026 11:59:18 GMTSarepta Shares Rise As Company Begins Enrollment In Gene Therapy Safety Enhancement Study - Stocktwits
Sat, 08 Aug 2026 10:47:29 GMTSarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer - simplywall.st
Fri, 07 Aug 2026 17:26:02 GMTSarepta Stock Dips After Hours: DMD Drug Blow And CEO Exit Eclipse Q4 Revenue Beat - Stocktwits
Fri, 07 Aug 2026 14:55:22 GMTState Street (NYSE: STT) discloses 8.4% Sarepta Therapeutics ownership via Schedule 13G - Stock Titan
Fri, 07 Aug 2026 12:06:44 GMTSarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy - Stocktwits

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sarepta Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.